174 related articles for article (PubMed ID: 37837735)
1. Circulating tumor-tissue modified HPV DNA testing in the clinical evaluation of patients at risk for HPV-positive oropharynx cancer: The IDEA-HPV study.
Batool S; Sethi RKV; Wang A; Dabekaussen K; Egloff AM; Del Vecchio Fitz C; Kuperwasser C; Uppaluri R; Shin J; Rettig EM
Oral Oncol; 2023 Dec; 147():106584. PubMed ID: 37837735
[TBL] [Abstract][Full Text] [Related]
2. Performance of Liquid Biopsy for Diagnosis and Surveillance of Human Papillomavirus-Associated Oropharyngeal Cancer.
Ferrandino RM; Chen S; Kappauf C; Barlow J; Gold BS; Berger MH; Westra WH; Teng MS; Khan MN; Posner MR; Misiukiewicz KJ; Bakst RL; Sindhu KK; Genden EM; Chai RL; Roof SA
JAMA Otolaryngol Head Neck Surg; 2023 Nov; 149(11):971-977. PubMed ID: 37422913
[TBL] [Abstract][Full Text] [Related]
3. Detection of circulating tumor human papillomavirus DNA before diagnosis of HPV-positive head and neck cancer.
Rettig EM; Faden DL; Sandhu S; Wong K; Faquin WC; Warinner C; Stephens P; Kumar S; Kuperwasser C; Richmon JD; Uppaluri R; Varvares M; Sethi R; Hanna GJ; Sroussi H
Int J Cancer; 2022 Oct; 151(7):1081-1085. PubMed ID: 35262203
[TBL] [Abstract][Full Text] [Related]
4. Preoperative Circulating Tumor HPV DNA and Oropharyngeal Squamous Cell Disease.
Lam D; Sangal NR; Aggarwal A; Rajasekaran K; Cannady SB; Basu D; Chalian A; Weinstein G; Brody RM
JAMA Otolaryngol Head Neck Surg; 2024 May; 150(5):444-450. PubMed ID: 38573644
[TBL] [Abstract][Full Text] [Related]
5. Detection of Occult Recurrence Using Circulating Tumor Tissue Modified Viral HPV DNA among Patients Treated for HPV-Driven Oropharyngeal Carcinoma.
Berger BM; Hanna GJ; Posner MR; Genden EM; Lautersztain J; Naber SP; Del Vecchio Fitz C; Kuperwasser C
Clin Cancer Res; 2022 Oct; 28(19):4292-4301. PubMed ID: 35576437
[TBL] [Abstract][Full Text] [Related]
6. Association of Pretreatment Circulating Tumor Tissue-Modified Viral HPV DNA With Clinicopathologic Factors in HPV-Positive Oropharyngeal Cancer.
Rettig EM; Wang AA; Tran NA; Carey E; Dey T; Schoenfeld JD; Sehgal K; Guenette JP; Margalit DN; Sethi R; Uppaluri R; Tishler RB; Annino DJ; Goguen LA; Jo VY; Haddad RI; Hanna GJ
JAMA Otolaryngol Head Neck Surg; 2022 Dec; 148(12):1120-1130. PubMed ID: 36301568
[TBL] [Abstract][Full Text] [Related]
7. Molecular subclassification determined by human papillomavirus and epidermal growth factor receptor status is associated with the prognosis of oropharyngeal squamous cell carcinoma.
Nakano T; Yamamoto H; Nakashima T; Nishijima T; Satoh M; Hatanaka Y; Shiratsuchi H; Yasumatsu R; Toh S; Komune S; Oda Y
Hum Pathol; 2016 Apr; 50():51-61. PubMed ID: 26997438
[TBL] [Abstract][Full Text] [Related]
8. Extracapsular extension of neck nodes and absence of human papillomavirus 16-DNA are predictors of impaired survival in p16-positive oropharyngeal squamous cell carcinoma.
Freitag J; Wald T; Kuhnt T; Gradistanac T; Kolb M; Dietz A; Wiegand S; Wichmann G
Cancer; 2020 Jan; 126(9):1856-1872. PubMed ID: 32032442
[TBL] [Abstract][Full Text] [Related]
9. The prognostic role of sex, race, and human papillomavirus in oropharyngeal and nonoropharyngeal head and neck squamous cell cancer.
Fakhry C; Westra WH; Wang SJ; van Zante A; Zhang Y; Rettig E; Yin LX; Ryan WR; Ha PK; Wentz A; Koch W; Richmon JD; Eisele DW; D'Souza G
Cancer; 2017 May; 123(9):1566-1575. PubMed ID: 28241096
[TBL] [Abstract][Full Text] [Related]
10. Human papillomavirus genotype and oropharynx cancer survival in the United States of America.
Goodman MT; Saraiya M; Thompson TD; Steinau M; Hernandez BY; Lynch CF; Lyu CW; Wilkinson EJ; Tucker T; Copeland G; Peters ES; Altekruse S; Unger ER
Eur J Cancer; 2015 Dec; 51(18):2759-67. PubMed ID: 26602016
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the eighth TNM classification on p16-positive oropharyngeal squamous cell carcinomas in the Netherlands and the importance of additional HPV DNA testing.
Nauta IH; Rietbergen MM; van Bokhoven AAJD; Bloemena E; Lissenberg-Witte BI; Heideman DAM; Baatenburg de Jong RJ; Brakenhoff RH; Leemans CR
Ann Oncol; 2018 May; 29(5):1273-1279. PubMed ID: 29438466
[TBL] [Abstract][Full Text] [Related]
12. Human Papillomavirus Drives Tumor Development Throughout the Head and Neck: Improved Prognosis Is Associated With an Immune Response Largely Restricted to the Oropharynx.
Chakravarthy A; Henderson S; Thirdborough SM; Ottensmeier CH; Su X; Lechner M; Feber A; Thomas GJ; Fenton TR
J Clin Oncol; 2016 Dec; 34(34):4132-4141. PubMed ID: 27863190
[TBL] [Abstract][Full Text] [Related]
13. Prognostic implications of human papillomavirus status for patients with non-oropharyngeal head and neck squamous cell carcinomas.
Ko HC; Harari PM; Sacotte RM; Chen S; Wieland AM; Yu M; Baschnagel AM; Bruce JY; Kimple RJ; Witek ME
J Cancer Res Clin Oncol; 2017 Nov; 143(11):2341-2350. PubMed ID: 28752235
[TBL] [Abstract][Full Text] [Related]
14. The use of plasma circulating tumor DNA for early detection of oligometastatic disease in HPV positive oropharyngeal squamous cell carcinoma.
Zhang L; Freeman T; Sun S; Bhateja P; Cloyd JM; Rocco JW; Haring CT
Oral Oncol; 2023 Apr; 139():106357. PubMed ID: 36905900
[No Abstract] [Full Text] [Related]
15. Nonuniform Distribution of High-risk Human Papillomavirus in Squamous Cell Carcinomas of the Oropharynx: Rethinking the Anatomic Boundaries of Oral and Oropharyngeal Carcinoma From an Oncologic HPV Perspective.
Gelwan E; Malm IJ; Khararjian A; Fakhry C; Bishop JA; Westra WH
Am J Surg Pathol; 2017 Dec; 41(12):1722-1728. PubMed ID: 28877058
[TBL] [Abstract][Full Text] [Related]
16. HPV-related squamous cell carcinoma of the head and neck: An update on testing in routine pathology practice.
Bishop JA; Lewis JS; Rocco JW; Faquin WC
Semin Diagn Pathol; 2015 Sep; 32(5):344-51. PubMed ID: 25724476
[TBL] [Abstract][Full Text] [Related]
17. Cell-free human papillomavirus DNA kinetics after surgery for human papillomavirus-associated oropharyngeal cancer.
O'Boyle CJ; Siravegna G; Varmeh S; Queenan N; Michel A; Pang KCS; Stein J; Thierauf JC; Sadow PM; Faquin WC; Wang W; Deschler DG; Emerick KS; Varvares MA; Park JC; Clark JR; Chan AW; Busse PM; Corcoran RB; Wirth LJ; Lin DT; Iafrate AJ; Richmon JD; Faden DL
Cancer; 2022 Jun; 128(11):2193-2204. PubMed ID: 35139236
[TBL] [Abstract][Full Text] [Related]
18. Validation of the VisionArray® Chip Assay for HPV DNA Testing in Histology Specimens of Oropharyngeal Squamous Cell Carcinoma.
Channir HI; Bendtsen SK; Melchior LC; Sandholm PR; Mordhorst C; Carlander AF; von Buchwald C; Kiss K
Head Neck Pathol; 2024 Mar; 18(1):27. PubMed ID: 38536624
[TBL] [Abstract][Full Text] [Related]
19. Cytology and direct human papillomavirus testing on fine needle aspirates from cervical lymph node metastases of patients with oropharyngeal squamous cell carcinoma or occult primary.
Rollo F; Dona' MG; Pellini R; Pichi B; Marandino F; Covello R; Benevolo M
Cytopathology; 2018 Oct; 29(5):449-454. PubMed ID: 29873841
[TBL] [Abstract][Full Text] [Related]
20. Developing a new diagnostic algorithm for human papilloma virus associated oropharyngeal carcinoma: an investigation of HPV DNA assays.
Cohen N; Gupta M; Doerwald-Munoz L; Jang D; Young JE; Archibald S; Jackson B; Lee J; Chernesky M
J Otolaryngol Head Neck Surg; 2017 Feb; 46(1):11. PubMed ID: 28193254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]